• Monday, February 04th, 2008
UroToday.com- The study out of Germany in the November 2007 issue of Pediatric Nephrology focused on acute focal bacterial nephritis in children. The group gives the definition of acute focal bacterial nephritis formerly known as lobar nephronia as a rare form of interstitial bacterial nephritis.
• Monday, February 04th, 2008
In the early view version of The Journal of Urology, Dr. Crook and colleagues present a single practitioner series of 125I prostate brachytherapy with analysis of long-term sequelae.Patients with low-risk prostate cancer (CaP) were initially assessed with an I-PSS questionnaire and given a short course of androgen deprivation therapy for prostates larger than 50cc.
• Monday, February 04th, 2008
UroToday.com- This is a sobering report that notes 352 reported problems using a variety of hemostatic devices to secure the renal hilum during laparoscopic nephrectomy between 1992-2006. While the majority of complications were noted using a stapling device vs.
• Monday, February 04th, 2008
UroToday.com- A prospective randomized trial by Dr. Northouse and associates published in the December issue of Cancer suggests that prostate cancer (CaP) patients and their spouses benefit from family intervention counseling. Interestingly, spouses benefited more.Both CaP and treatment related side effects can have a negative effect on patients and their spouses.
• Monday, February 04th, 2008
UroToday.com- This article evaluates the prognostic ability of lymph node density in predicting disease-specific survival in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder without neoadjuvant chemotherapy.
• Monday, February 04th, 2008
SynflorixTM (Pneumococcal Haemophilus influenzae Protein D conjugate vaccine) has beenaccepted for review by the European Medicines Agency (EMEA), GlaxoSmithKline (GSK) announced. The 10-valent vaccine is designed to protect children against both invasive pneumococcal disease (IPD) and bacterial respiratory infections such as acute middle ear infections (otitis media).
• Monday, February 04th, 2008
Bayer has been granted marketing approval of NexavarŽ in Japan for the treatment of advanced renall cell carcinoma (RCC), the most common form of kidney cancer. Nexavar is an oral multi-kinase inhibitor jointly developed by Bayer HealthCare AG and Onyx Pharmaceuticals, Inc. which targets both the tumor cell and tumor vasculature.
• Monday, February 04th, 2008
Dietary Evidence for Prevention and Treatment of Cardiovascular DiseaseFebruary is American Heart Month and, to mark the occasion, the Journal of the American Dietetic Association has published a comprehensive review of dietary factors for treating and preventing cardiovascular disease.
• Monday, February 04th, 2008
A brief bout of non-REM sleep (45 minutes) obtained during a daytime nap clearly benefits a person's declarative memory performance, according to a study published in the February 1 issue of the journal SLEEP.The study, authored by Matthew A.
• Monday, February 04th, 2008
Four days' exposure to a REM sleep deprivation procedure reduces cell proliferation in the part of the forebrain that contributes to long-term memory of rats, according to a study published in the February 1 issue of the journal SLEEP.The study, authored by Dennis McGinty, PhD, of the V.A. Greater Los Angeles Healthcare System, focused on male Sprague-Dawley rats.
Recent Comments